Full-service, functional outsourcing, and specialist-vendor blends create different sponsor burdens once work begins.
Comparison guide
CRO comparison works best when you compare delivery risk, not just service menus.
A useful CRO comparison should show where each vendor fits the study, where execution may break down, and why one delivery model may be safer than another for the sponsor team behind it.
The bid team is not the delivery team. Good comparison means pressure-testing real operating ownership.
The right CRO for oncology Phase II in Europe is not automatically the right CRO for a broader global build.
Public signals, peer review evidence, and shortlist rationale are more useful than generic vendor positioning.
What to score in a CRO comparison
- Delivery model fit to the study and sponsor team.
- Phase and therapeutic-area relevance.
- Biometrics, central lab, and specialist-vendor integration.
- Escalation visibility and sponsor attention model.
- Operational weaknesses repeated in public and peer signals.
What weak comparison looks like
- Comparing service lists without testing actual delivery mechanics.
- Defaulting to brand familiarity rather than study fit.
- Skipping specialist dependencies until after the CRO decision is nearly made.
- Running the shortlist as procurement admin instead of execution risk control.
Use CVC
Build a CRO shortlist you can defend.
Use the directory to compare candidates, then move into sponsor support when the shortlist needs pressure-testing.
Related guides
Best CRO for biotechBest CRO for oncology
Clinical vendor selection